News

Published on 14 Mar 2022 on ETF DAILY NEWS

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Rises By 154.5%


Article preview image

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) was the recipient of a significant increase in...

NASDAQ.ENSC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Ensysce receives FDA guidance on opioid with overdose protection

Ensysce receives FDA guidance on opioid with overdose protection

Investing.com 21 Feb 2024

Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Why

Ensysce Biosciences Inc (NASDAQ:ENSC) received an FDA Breakthrough Therapy Designation (BTD) for ...

Benzinga via Yahoo Finance 22 Jan 2024

Why Are Ensysce Biosciences Shares Are Trading Higher Today

Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the c...

Benzinga via Yahoo Finance 10 May 2023

10 Stocks Targeted By Short Sellers Recently

In this piece, we will take a look at ten stocks targeted by short sellers recently. For more sto...

Insider Monkey via Yahoo Finance 22 Apr 2023

10 Penny Stocks with Insider Buying

In this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks...

Insider Monkey via Yahoo Finance 9 Mar 2023

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's...

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's...

Investing.com 9 Dec 2022

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.00% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.00%

Investing.com 7 Dec 2022

Retired Pepperdine University President named UCO Interim President

The University of Central Oklahoma says the former President of Pepperdine University in Malibu,...

Oklahoma's NewsChannel 4 19 Nov 2022

Ensysce Biosciences' Newly Formulated Oxycodone Product Shows Resistance To Tampering, Abuse

Ensysce Biosciences Inc (NASDAQ: ENSC) announced topline results from a human abuse potential (HA...

Benzinga via Yahoo Finance 31 Oct 2022

Ensysce Biosciences, Quotient Partner To Work On Novel Opioid To Prevent Abuse and Overdose

Ensysce Biosciences Inc (NASDAQ: ENSC) and Quotient Sciences, a drug development and manufacturin...

Benzinga via Yahoo Finance 1 Sep 2022